Treating nausea and vomiting in palliative care: a review
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Nausea and vomiting are portrayed in the specialist palliative care literature as common and distressing symptoms affecting the majority of patients with advanced cancer and other life-limiting illnesses. However, recent surveys indicate that these symptoms may be less common and bothersome than has previously been reported. The standard palliative care approach to the assessment and treatment of nausea and vomiting is based on determining the cause and then relating this back to the "emetic pathway" before prescribing drugs such as dopamine antagonists, antihistamines, and anticholinergic agents which block neurotransmitters at different sites along the pathway. However, the evidence base for the effectiveness of this approach is meager, and may be in part because relevance of the neuropharmacology of the emetic pathway to palliative care patients is limited. Many palliative care patients are over the age of 65 years, making these agents difficult to use. Greater awareness of drug interactions and QT(c) prolongation are emerging concerns for all age groups. The selective serotonin receptor antagonists are the safest antiemetics, but are not used first-line in many countries because there is very little scientific rationale or clinical evidence to support their use outside the licensed indications. Cannabinoids may have an increasing role. Advances in interventional gastroenterology are increasing the options for nonpharmacological management. Despite these emerging issues, the approach to nausea and vomiting developed within palliative medicine over the past 40 years remains relevant. It advocates careful clinical evaluation of the symptom and the person suffering it, and an understanding of the clinical pharmacology of medicines that are available for palliating them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389 · cited 1×
“All are problematic in geriatric populations, but diphenhydramine and hydroxyzine have a high risk for a severe adverse outcome on the Beers criteria, which rate a drug’s tendency to cause side effects in the elderly due to the physiologic changes of aging.(93) Therefore, they are the least desirable in this populatio…”
Solano, J. P., Gomes, B., & Higginson, I. J. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.06.007 · Cited by 1,191
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
Prevalence of symptoms among patients with advanced cancer: An international collaborative study
Vainio, A., & Auvinen, A. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(96)00042-5 · Cited by 455
Clinical practice guidelines for the psychosocial care of adults with cancer
Turner, J., Zapart, S., Pedersen, K., Rankin, N., Luxford, K., & Fletcher, J. (2005) · Psycho-Oncology · doi:10.1002/pon.897 · Cited by 451
Symptom clusters in patients with advanced cancers
Cheung, W. Y., Le, L. W., & Zimmermann, C. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0577-7 · Cited by 166
Passik, S. D., Lundberg, J., Kirsh, K. L., Theobald, D., Donaghy, K., Holtsclaw, E., Cooper, M., & Dugan, W. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00391-3 · Cited by 154 · cited 1×
“Two small case series with subjective outcome assessment indicated that olanzapine appears to be effective in cases that were refractory to other agents.(86) • Levomepromazine – there have not been any randomized controlled trials of levomepromazine in palliative care.”
Cited by
Symptom burden in heart failure: assessment, impact on outcomes, and management
Alpert, C. M., Smith, M. A., Hummel, S. L., & Hummel, E. K. (2017) · Heart Failure Reviews · doi:10.1007/s10741-016-9581-4 · Cited by 304
Nausea and Vomiting: a Palliative Care Imperative
Wickham, R. J. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-0871-6 · Cited by 40
MacKintosh, D. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2015.0224 · Cited by 33
“Traditionally it has been taught that therapy should be selected to correspond to purported relevant neurotransmitters in the emetic pathway, although that view has been challenged.(1) In practice this is frequently difficult to do and in this series would not have been possible in all cases.”
Harder, S., Groenvold, M., Isaksen, J., Sigaard, J., Frandsen, K. B., Neergaard, M. A., Mondrup, L., & Herrstedt, J. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-018-4593-3 · Cited by 17
Metadata
- Authors
- Glare, P., Miller, J., Nikolova, & Tickoo
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2011-09
- Volume
- 6
- Pages
- 243
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- OpenAlex
- W1983259118
- Cited by
- 165
- References
- 7
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating nausea and vomiting in palliative care: a review. https://app.cochat.ai/papers/10.2147/cia.s13109
- The paper
- Glare, P., Miller, J., Nikolova, & Tickoo. (2011). Treating nausea and vomiting in palliative care: a review. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s13109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.